NDC 44911-0664
Influenzinum 200C
Influenzinum (2022-2023)
Influenzinum 200C is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Energique, Inc.. The primary component is Influenza A Virus A/darwin/9/2021 Ivr-228 (h3n2) Antigen (uv, Formaldehyde Inactivated); Influenza A Virus A/victoria/2570/2019 Ivr-215 (h1n1) Antigen (uv, Formaldehyde Inactivated); Influenza B Virus B/austria/1359417/2021 Bvr-26 Antigen (uv, Formaldehyde Inactivated); Influenza B Virus B/phuket/3073/2013 Antigen (uv, Formaldehyde Inactivated).
| Product ID | 44911-0664_98bf0f3c-1216-4f98-9342-bdac8a80736b |
| NDC | 44911-0664 |
| Product Type | Human Otc Drug |
| Proprietary Name | Influenzinum 200C |
| Generic Name | Influenzinum (2022-2023) |
| Dosage Form | Liquid |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-12-29 |
| Marketing Category | UNAPPROVED HOMEOPATHIC / |
| Labeler Name | Energique, Inc. |
| Substance Name | INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) |
| Active Ingredient Strength | 200 [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2024-12-31 |